Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country
低资源国家真实世界数据显示,接受瑞博西尼联合芳香化酶抑制剂或氟维司群治疗的HR阳性、HER2阴性转移性乳腺癌患者的临床结果
期刊:ImmunoTargets and Therapy
影响因子:4.4
doi:10.2147/ITT.S479153
Abdel-Razeq, Hikmat; Sharaf, Baha; Khater, Suhaib; Baidoun, Huda Jafar; Bani Hani, Hira; Taqash, Ayat; El Khatib, Osama; Edaily, Sarah; Abunasser, Mahmoud; Tamimi, Faris; Al-Masri, Yosra Nabeel; Al-Batsh, Tamer Moh'd Waleed; Zayed, Anas; Ghatasheh, Tala; Radaideh, Tala